PTC Therapeutics, Inc. provides revenue guidance for the full-year of 2024. For the year, company expects total revenues to be between $600 million and $850 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.93 USD | -0.23% |
|
+1.14% | +12.23% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.23% | 2.37B | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- PTC Therapeutics, Inc. Provides Revenue Guidance for the Full-Year of 2024